# Bioequivalence (BE) Study Between YHP2205 and YHR2401 in Healthy Volunteers

> **NCT06775522** · PHASE1 · COMPLETED · sponsor: **Yuhan Corporation** · enrollment: 60 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** YHP2205
- **DRUG:** YHR2401

## Key facts

- **NCT ID:** NCT06775522
- **Lead sponsor:** Yuhan Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-11
- **Primary completion:** 2025-01-20
- **Final completion:** 2025-01-21
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06775522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06775522, "Bioequivalence (BE) Study Between YHP2205 and YHR2401 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06775522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*